LGALS3 and cancer: Thus, the C. japonicus enzyme has been regarded as the most promising candidate for the production at scale of galactose-rich PGOs with PD < 4 for its potential application for recognition to cancer cells (i.e., as inhibitor of pro-metastasic Galectin 3).